In het document van de Raad van Europa “Pathogen inactivation of labile Blood products” wordt het volgende besloten:” Pathogen inactivation of labile blood products will diminish the risk of transfusion-transmitted disease and immunomodulatory disturbances.
Dans le document du Conseil de l’Europe “Pathogen inactivation of labile Blood products”, la conclusion est la suivante : ” Pathogen inactivation of labile blood products will diminish the risk of transfusion-transmitted disease and immunomodulatory disturbances.
